These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38639508)

  • 1. Risk and benefit of reinitiating antiplatelet therapy after spontaneous intracerebral hemorrhage: a systematic review and meta-analysis.
    Zhang JW; Zhao JX; Yin GF
    Eur Rev Med Pharmacol Sci; 2024 Apr; 28(7):2686-2695. PubMed ID: 38639508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic treatment after stroke due to intracerebral haemorrhage.
    Cochrane A; Chen C; Stephen J; Rønning OM; Anderson CS; Hankey GJ; Al-Shahi Salman R
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012144. PubMed ID: 36700520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antiplatelet therapy on the incidence, prognosis, and rebleeding of intracerebral hemorrhage.
    Li Y; Liu X; Chen S; Wang J; Pan C; Li G; Tang Z
    CNS Neurosci Ther; 2023 Jun; 29(6):1484-1496. PubMed ID: 36942509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage: Extended Follow-up of the RESTART Randomized Clinical Trial.
    Al-Shahi Salman R; Dennis MS; Sandercock PAG; Sudlow CLM; Wardlaw JM; Whiteley WN; Murray GD; Stephen J; Rodriguez A; Lewis S; Werring DJ; White PM;
    JAMA Neurol; 2021 Oct; 78(10):1179-1186. PubMed ID: 34477823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet agents for chronic kidney disease.
    Palmer SC; Di Micco L; Razavian M; Craig JC; Perkovic V; Pellegrini F; Jardine MJ; Webster AC; Zoungas S; Strippoli GF
    Cochrane Database Syst Rev; 2013 Feb; (2):CD008834. PubMed ID: 23450589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet agents for the treatment of deep venous thrombosis.
    Flumignan CD; Nakano LC; Baptista-Silva JC; Flumignan RL
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012369. PubMed ID: 35876829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Antiplatelet Resumption and the Risks of Major Bleeding After Intracerebral Hemorrhage.
    Liu CH; Wu YL; Hsu CC; Lee TH
    Stroke; 2023 Feb; 54(2):537-545. PubMed ID: 36621820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack.
    Naqvi IA; Kamal AK; Rehman H
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD009716. PubMed ID: 32813275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.
    Lee M; Saver JL; Hong KS; Rao NM; Wu YL; Ovbiagele B
    Ann Intern Med; 2013 Oct; 159(7):463-70. PubMed ID: 24081287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Effects of Dual Antiplatelet Therapy or Aspirin Monotherapy after Acute Minor Ischemic Stroke or Transient Ischemic Attack, a Meta-Analysis.
    Condello F; Liccardo G; Ferrante G
    Curr Pharm Des; 2021; 27(40):4140-4146. PubMed ID: 34323179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic therapy for secondary prevention in patients with stroke or transient ischemic attack: A multiple treatment network meta-analysis of randomized controlled trials.
    Tornyos D; Komócsi A; Bálint A; Kupó P; El Abdallaoui OEA; Szapáry L; Szapáry LB
    PLoS One; 2022; 17(8):e0273103. PubMed ID: 35976963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy.
    Desai A; Escamilla-Ocanas C; Dilip D; Saber H; Damani R
    J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105654. PubMed ID: 33578352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
    Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
    Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Meta-analysis on the efficacy and adverse events of aspirin plus clopidogrel versus aspirin-monotherapy in patients with ischemic stroke or transient ischemic attack].
    Yang C; Qian J; Tang X; Gao P; Hu Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1430-5. PubMed ID: 26850406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet Therapy After Spontaneous Intracerebral Hemorrhage and Functional Outcomes.
    Murthy SB; Biffi A; Falcone GJ; Sansing LH; Torres Lopez V; Navi BB; Roh DJ; Mandava P; Hanley DF; Ziai WC; Kamel H; Rosand J; Sheth KN;
    Stroke; 2019 Nov; 50(11):3057-3063. PubMed ID: 31895618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of platelet transfusion on functional independence and mortality after antiplatelet therapy associated spontaneous intracerebral hemorrhage: A systematic review and meta-analysis.
    Morris NA; Patel N; Galvagno SM; Ludeman E; Schwartzbauer GT; Pourmand A; Tran QK
    J Neurol Sci; 2020 Oct; 417():117075. PubMed ID: 32763508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual versus mono antiplatelet therapy for acute non-cardioembolic ischaemic stroke or transient ischaemic attack: a systematic review and meta-analysis.
    Yang Y; Zhou M; Zhong X; Wang Y; Zhao X; Liu L; Wang Y
    Stroke Vasc Neurol; 2018 Jun; 3(2):107-116. PubMed ID: 30022798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet Agent Use After Stroke due to Intracerebral Hemorrhage.
    Al-Shahi Salman R; Greenberg SM
    Stroke; 2023 Dec; 54(12):3173-3181. PubMed ID: 37916459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effects of restarting antiplatelet therapy in patients with intracerebral hemorrhage.
    Jung NY; Cho J
    Clin Neurol Neurosurg; 2022 Sep; 220():107361. PubMed ID: 35835024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.